No Data
No Data
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics Price Target Announced at $70.00/Share by Wells Fargo
Vera Therapeutics (VERA) Gets a Buy From J.P. Morgan
Wells Fargo Initiates Vera Therapeutics(VERA.US) With Buy Rating, Announces Target Price $70
Express News | Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer
Press Release: Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer